B-MYB transactivates its own promoter through SP1-binding sites

被引:42
作者
Sala, A
Saitta, B
De Luca, P
Cervellera, MN
Casella, I
Lewis, RE
Watson, R
Peschle, C
机构
[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Mol Pharmacol & Pathol, I-66030 Santa Maria Imbaro, CH, Italy
[2] Thomas Jefferson Univ, Kimmel Canc Inst, Dept Immunol Microbiol, Philadelphia, PA 19107 USA
[3] Dept Reumatol, Philadelphia, PA 19107 USA
[4] Univ Naples Federico II, Dept Genet Mol & Gen Biol, I-80134 Naples, Italy
[5] Univ Nebraska, Med Ctr, Eppley Canc Inst, Omaha, NE 68198 USA
[6] St Marys Hosp, Sch Med, Ludwig Inst Canc Res, London W2 1PG, England
[7] Ist Super Sanita, Lab Ematol Oncol, I-00161 Rome, Italy
关键词
B-MYB; cell-cycle; promoter; SP1; transcription;
D O I
10.1038/sj.onc.1202421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
B-MYB is an ubiquitous protein required for mammalian cell growth. In this report we show that B-MYB transactivates its own promoter through a 120 bp segment proximal to the transcription start site. The B-MYB-responsive element does not contain myb-binding sites and gel-shift analysis shows that SP1, but not B-MYB, protein contained in SAOS2 cell extracts binds to the 120 bp B-myb promoter fragment. B-MYB-dependent transactivation is cooperatively increased in the presence of SP1, but not SP3 overexpression, When the SP1 elements of the B-myb promoter are transferred in front of a heterologous promoter, an increased response to B-MYB results. In contrast, c-MYB, the prototype member of the Myb family, is not able to activate the luciferase construct containing the SP1 elements. With the use of an SP1-GAL4 fusion protein, we have determined that the cooperative activation occurs through the domain A of SP1, These observations suggest that B-MYB functions as a coactivator of SP1, and that diverse combinations of myb and SP1 sites may dictate the responsiveness of myb-target genes to the various members of the myb family.
引用
收藏
页码:1333 / 1339
页数:7
相关论文
共 38 条
[21]  
Lin SY, 1996, MOL CELL BIOL, V16, P1668
[22]   THE ROLE OF MYB PROTEINS IN NORMAL AND NEOPLASTIC CELL-PROLIFERATION [J].
LYON, J ;
ROBINSON, C ;
WATSON, R .
CRITICAL REVIEWS IN ONCOGENESIS, 1994, 5 (04) :373-388
[23]   DIFFERENT MEMBERS OF THE SP1 MULTIGENE FAMILY EXERT OPPOSITE TRANSCRIPTIONAL REGULATION OF THE LONG TERMINAL REPEAT OF HIV-1 [J].
MAJELLO, B ;
DELUCA, P ;
HAGEN, G ;
SUSKE, G ;
LANIA, L .
NUCLEIC ACIDS RESEARCH, 1994, 22 (23) :4914-4921
[24]  
Marhamati DJ, 1996, J BIOL CHEM, V271, P3359
[25]  
MERIKA M, 1995, MOL CELL BIOL, V15, P2437
[26]   THE V-MYB ONCOGENE PRODUCT BINDS TO AND ACTIVATES THE PROMYELOCYTE-SPECIFIC MIM-1 GENE [J].
NESS, SA ;
MARKNELL, A ;
GRAF, T .
CELL, 1989, 59 (06) :1115-1125
[27]   ISOLATION OF HUMAN CDNA CLONES OF MYB-RELATED GENES, A-MYB AND B-MYB [J].
NOMURA, N ;
TAKAHASHI, M ;
MATSUI, M ;
ISHII, S ;
DATE, T ;
SASAMOTO, S ;
ISHIZAKI, R .
NUCLEIC ACIDS RESEARCH, 1988, 16 (23) :11075-11089
[28]   Involvement of the Sp3 transcription factor in induction of p2(Cip1/WAF1) in keratinocyte differentiation [J].
Prowse, DM ;
Bolgan, L ;
Molnar, A ;
Dotto, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) :1308-1314
[29]   REQUIREMENT OF B-MYB FUNCTION FOR SURVIVAL AND DIFFERENTIATIVE POTENTIAL OF HUMAN NEUROBLASTOMA-CELLS [J].
RASCHELLA, G ;
NEGRONI, A ;
SALA, A ;
PUCCI, S ;
ROMEO, A ;
CALABRETTA, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8540-8545
[30]   A VECTOR FOR EXPRESSING GAL4(1-147) FUSIONS IN MAMMALIAN-CELLS [J].
SADOWSKI, I ;
PTASHNE, M .
NUCLEIC ACIDS RESEARCH, 1989, 17 (18) :7539-7539